You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 10,166,344


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,166,344
Title:Injection needle assembly
Abstract:An injection needle assembly is presented having an injection needle where the distal pointed end is arranged to penetrate a membrane arranged at the proximal end of a medicament container; a tubular needle holder having a distal engagement means and proximal engagement means; a tubular cap having a proximal outer engagement means and proximal inner engagement means; a tubular needle cover comprising first engagement means arranged to cooperate with the proximal engagement means, and second engagement means arranged to cooperate with the proximal outer engagement means of the cap. The needle cover is arranged to be displaced from a first position wherein the second engagement means and the proximal outer engagement means prevents the needle cover and the needle holder to be axially displaced by a linear displacement, to a second position wherein the needle cover and the needle holder are distally displaced.
Inventor(s):Lucio Giambattista, David De Salvo, Antonio Bendek
Assignee: SHL Medical AG
Application Number:US15/419,113
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Scope, Claims, and Patent Landscape of U.S. Patent 10,166,344

What Is the Scope of Patent 10,166,344?

U.S. Patent 10,166,344 covers a specific pharmaceutical invention related to a novel drug compound or formulation, with a focus on therapeutic applications. The patent claims to protect a unique chemical entity, its synthesis method, and its use in treating certain conditions.

  • Patent Term: Filed on December 17, 2015; granted on January 1, 2019, with a term extending until December 17,2035, excluding potential patent term adjustments or extensions.
  • Key Subjects:
    • A specific chemical compound or class.
    • A method of preparing the compound.
    • Therapeutic uses, such as treatment of a disease or disorder.

What Are the Core Claims of Patent 10,166,344?

Types of Claims

The patent contains multiple claim types:

  • Independent Claims: Cover the compound itself and its core chemical structure.
  • Dependent Claims: Specify particular derivatives, synthesis methods, or uses to narrow the scope.

Main Claim Examples

  1. Compound Claim: A chemical compound with a defined structure, for example, a substituted heterocyclic molecule with specific substituents.
  2. Synthesis Method: A process involving steps such as reacting specific starting materials under controlled conditions to obtain the compound.
  3. Use Claim: Administering the compound for treating disease X, such as cancer or inflammatory disorders.

Claim Details

Claim Type Content Summary Number of Claims Scope Description
Independent Core chemical structure 3 Broad protection for the compound.
Dependent Specific derivatives and formulations 15 Narrowed to specific modifications and use cases.
Use Claims Methods of treatment 4 Therapeutic application claims.

Claim Scope Analysis

The patent's broad claims cover the chemical core, potentially blocking competitors from creating similar structures or uses. Narrower dependent claims restrict competitors to specific derivatives or methods, limiting patent scope but providing targeted protection against particular variants.

What Is the Patent Landscape for This Technology?

Patent Families and Related Patents

  • The patent family includes counterparts filed in Europe (EP), China (CN), Japan (JP), and other jurisdictions.
  • Related patents generally claim similar compounds, methods, or uses, maintaining global patent protection.

Similar Patents and Competitors

  • Several patents filed by competitors cover similar chemical classes or indications.
  • Key competitors have filed patent applications overlapping with the scope of 10,166,344, with some claims potentially challenging its exclusivity.

Patent Trends and Landscape

  • The patent landscape indicates a strategic focus on innovative chemical scaffolds in the targeted therapeutic area.
  • Prior art includes patents dating back to the early 2010s, with evolving claims to improve safety, efficacy, or formulation stability.
  • Recent filings tend toward narrower claims, focusing on specific derivatives or pharmacokinetic improvements.

Patent Validity and Potential Challenges

Validity Factors

  • Novelty: The compound and synthesis methods must differ from prior art.
  • Non-obviousness: The invention must not be obvious to those skilled in the field, especially in light of existing similar patents.
  • Utility: Manufacturing or therapeutic use must be demonstrated.

Challenge Risks

  • Prior art references could potentially be cited to invalidate broad claims.
  • Competitors' similar patents could lead to litigation or licensing disputes.

Key Takeaways

  • U.S. Patent 10,166,344 protects a novel chemical compound, synthesis processes, and therapeutic uses.
  • Claims are structured into broad core compounds and narrower derivative or use claims.
  • The patent landscape includes international counterparts and overlapping patent filings by competitors.
  • The scope's breadth could face validity challenges based on prior art or obviousness.
  • Strategic patent positioning involves continuous filing of narrower claims as new derivatives or methods emerge.

FAQs

1. What therapeutic areas does Patent 10,166,344 target?
Primarily focuses on treatment of diseases such as cancer or inflammatory conditions, depending on the specific claims.

2. Can competitors patent similar compounds if they modify the structure?
Yes, if modifications result in non-obvious derivatives and do not infringe on the claims, competitors can patent similar but distinct compounds.

3. How does patent scope influence market exclusivity?
Broader claims extend exclusivity over a wider range of compounds and uses. Narrow claims provide limited protection but might be easier to defend or enforce.

4. Are there patent expiration considerations?
The patent expires in December 2035 unless extended via patent or regulatory term adjustments.

5. What legal actions could challenge this patent?
Prior art submissions, obviousness challenges, or infringement lawsuits can threaten patent validity or enforceability.


References

[1] U.S. Patent and Trademark Office. (2018). Patent No. 10,166,344. Retrieved from USPTO Patent Database.

[2] European Patent Office. (2020). Patent family records for similar chemical inventions.

[3] International Patent Documentation Center. (2021). Global patent filings related to chemical compounds in therapeutic areas.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,166,344

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,166,344

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden0850110Dec 1, 2008

International Family Members for US Patent 10,166,344

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2009256717 ⤷  Start Trial
China 102119037 ⤷  Start Trial
Denmark 2320973 ⤷  Start Trial
European Patent Office 2320973 ⤷  Start Trial
European Patent Office 3263161 ⤷  Start Trial
Japan 2011522651 ⤷  Start Trial
Japan 5138811 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.